Property Name |
Property Value |
Unit |
Raw Value |
Raw Unit |
Annotation |
Factor |
Reference |
Absorption |
50.0 |
% |
~40-60 |
% |
|
|
DRUGBANK |
Bioavailability |
9.0 |
% |
4-14 |
% |
|
|
DRUGBANK |
Clearance |
52.0 |
L/h |
52.0 |
L/h |
intravenous injection, IV; |
|
DRUGBANK |
Clearance |
0.75 |
L/h/kg |
12.5 |
ml/min/kg |
intravenous injection, IV; human, homo sapiens; |
|
Human Intravenous Pharmacokinetic Dataset |
Volume of Distribution |
18.0 |
L |
18.0 |
L |
|
|
DRUGBANK |
Volume of Distribution |
0.25 |
L/kg |
0.25 |
L/kg |
intravenous injection, IV; human, homo sapiens; |
|
Human Intravenous Pharmacokinetic Dataset |
Half-life |
6.0 |
h |
6 |
h |
elimination half-life; |
|
DRUGBANK |
Half-life |
10.0 |
h |
10 |
h |
elimination half-life; |
|
DRUGBANK |
Half-life |
20.0 |
h |
16-24 |
h |
effective half-life; |
|
DRUGBANK |
Half-life |
0.26 |
h |
0.26 |
h |
intravenous injection, IV; human, homo sapiens; |
|
Human Intravenous Pharmacokinetic Dataset |
Toxicity LD50 |
4875.0 |
mg/kg |
4875.0 |
mg/kg |
PO, oral; female mouse; |
|
DRUGBANK |
Toxicity LD50 |
3990.0 |
mg/kg |
3990.0 |
mg/kg |
PO, oral; male mouse; |
|
DRUGBANK |
Eliminate Route |
66.0 |
% |
~66 |
% |
Faeces excretion; PO, oral; |
|
DRUGBANK |
Eliminate Route |
33.0 |
% |
~33 |
% |
Urinary excretion; PO, oral; |
|
DRUGBANK |
Protein Binding |
80.0 |
% |
~80 |
% |
|
Plasma Concentration → ; |
DRUGBANK |